Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2012
09/18/2012CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/13/2012WO2012122533A2 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
09/13/2012WO2012122282A1 Low cell toxicity antibiotic hygromycin b
09/13/2012WO2012121469A1 Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol
09/13/2012WO2012121424A1 Novel oxazolidinone derivative having cyclic amidrazone group and pharmaceutical composition containing same
09/13/2012WO2012121079A1 Compound and method for producing same, as well as method for producing oseltamivir phosphate
09/13/2012WO2012120397A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012WO2012120129A1 Methods and pharmaceutical composition for the treatment of infectious diseases
09/13/2012WO2012120054A1 Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
09/13/2012WO2012119972A1 Conjugation process
09/13/2012WO2012119870A1 Oleyl phosphocholine for the treatment of mycosis
09/13/2012WO2012119846A1 Synthetic lta mimetics and use thereof as vaccine component for therapy and/or pro-phylaxis against gram-positive infections
09/13/2012WO2012119769A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccine
09/13/2012WO2012119699A1 Alcoholic extract of fungi of genus cunninghamella and use thereof
09/13/2012WO2012119366A1 Β-lactam compound antibiotic composition
09/13/2012WO2012089833A3 Expression systems
09/13/2012WO2012079032A3 Compositions and methods of treating drug-resistant retroviral infections
09/13/2012WO2012071521A3 Adjuvant
09/13/2012WO2012026907A3 Cefpodoxime proxetil formulations
09/13/2012WO2011100838A8 Derivatives of 1-phenyl-1,5-dihydro-benzo[b] [1.4]diazepine-2.4-dione as inhibitors of hiv replication
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120232155 Novel antibacterial hydroxyphenyl compound
09/13/2012US20120232150 Phthalanilate compounds and methods of use
09/13/2012US20120232133 Delivery of proteins using adeno-associated virus (aav) vectors
09/13/2012US20120232129 Multiantivirus compound, composition and method for treatment of virus diseases
09/13/2012US20120232128 Treatment of influenza
09/13/2012US20120232126 Multi-targets interfering rna molecules and their applications
09/13/2012US20120232110 Antimicrobial Compounds
09/13/2012US20120232099 Compounds for the Treatment of Hepatitis C
09/13/2012US20120232085 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/13/2012US20120232083 Fluoro-pyridinone derivatives useful as antibacterial agents
09/13/2012US20120232079 Novel acylpiperazinones and their use as pharmaceuticals
09/13/2012US20120232077 Selective antibacterials for clostridium difficile infections
09/13/2012US20120232069 Process for preparing efavirenz polymorph
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232062 Azaindazoles to treat flaviviridae virus infection
09/13/2012US20120232048 Method for modulating gpr119 g protein-coupled receptor and selected compounds
09/13/2012US20120232047 Substituted clavulanic acid
09/13/2012US20120232040 Medication for clinical extensively-drug resistant acinetobacter baumannii
09/13/2012US20120232038 Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
09/13/2012US20120232035 Bicyclic pyrimidinones and uses thereof
09/13/2012US20120232034 Vesicular formulations
09/13/2012US20120232032 Antimicrobial and/or epithelial cell growth stimulating substance and composition and tissue dressing material
09/13/2012US20120232031 Injectable formulations for intra-articular or peri-articular administration
09/13/2012US20120232029 2',4'-substituted nucleosides as antiviral agents
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232006 Production of polyurethane foams
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231998 Organic compounds and their uses
09/13/2012US20120231997 Recombinant human cc10 protein for treatment of influenza
09/13/2012US20120231996 Phalloidin derivatives and methods for their synthesis
09/13/2012US20120231995 Use of pyrroloquinoline compounds to kill clinically latent microorganisms
09/13/2012US20120231143 Virus-inactivating agent
09/13/2012US20120231096 Composition and method of treating lipid encapsulated virus infections
09/13/2012US20120231095 Agents derived from holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
09/13/2012US20120231088 Use of Deuterium Oxide for the Treatment of Virus-Based Diseases of the Respiratory Tract
09/13/2012US20120231086 Protein matrix vaccines of improved immunogenicity
09/13/2012US20120231068 Virucidal properties of various forms of sophorolipids
09/13/2012US20120231048 Medical Devices and Implants from Nb-Ta-W-Zr Alloys
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231033 Inactivated poultry vaccine
09/13/2012US20120231030 Multi-epitopic vaccine
09/13/2012US20120231027 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
09/13/2012US20120231023 Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells
09/13/2012US20120231018 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231017 Heterocyclic aspartyl protease inhibitors
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120230957 Compositions and methods for treatment of pain
09/13/2012US20120230951 Antiviral compounds
09/13/2012US20120230949 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
09/13/2012US20120230947 Biologically active proteins having increased in vivo and/or in vitro stability
09/13/2012US20120230941 Methods for treating nervous system injury and disease
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012CA2829583A1 Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol
09/13/2012CA2829361A1 Peptide deformylase inhibitors
09/13/2012CA2829126A1 Synthetic lta mimetics and use thereof as vaccine component for therapy and/or pro-phylaxis against gram-positive infections
09/13/2012CA2829082A1 Heterocyclic modulators of lipid synthesis
09/13/2012CA2828909A1 Oleyl phosphocholine for the treatment of mycosis
09/13/2012CA2828787A1 Conjugation process
09/13/2012CA2828374A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccharide ps-ii, methods of synthesis and uses thereof, in particular as a vaccine
09/13/2012CA2828337A1 Fluoro-pyridinone derivatives useful as antibacterial agents
09/12/2012EP2497826A1 Method of producing a temperature sensitive (ts) influenza virus
09/12/2012EP2497779A1 Klebsiella antigens
09/12/2012EP2497770A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
09/12/2012EP2497493A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector
09/12/2012EP2497488A1 Method for treating delayed-type hypersensitivity reactions associated with changes of qualitative and/or quantitative composition of blood extracellular DNA
09/12/2012EP2497487A1 Method for treating diabetes and atherosclerosis associated with changes of qualitative and/quantitative composition of blood extracellular DNA
09/12/2012EP2497486A1 Method for treating diseases caused by fungi associated with changes of qualitative and/quantitative composition of blood extracellular DNA
09/12/2012EP2497482A1 Composition for preventing and treating influenza-virus-induced diseases
09/12/2012EP2497477A1 Alcoholic extract of fungi of genus Cunninghamella and use thereof
09/12/2012EP2497469A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
09/12/2012EP2497460A1 Methods of reducing microbial contamination
09/12/2012EP2497459A1 Methods of reducing microbial contamination
09/12/2012EP2496609A2 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
09/12/2012EP2496596A1 Therapeutic peptides
09/12/2012EP2496578A2 Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same
09/12/2012EP2496572A1 Benzimidazole-imidazole derivatives
09/12/2012EP2496563A1 Certain crystalline hydrates, pharmaceutical compositions thereof and methods for preparation and use thereof
09/12/2012EP2496239A2 Copper salts of ion exchange materials for use in the treatment and prevention of infections
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1798